Unilab Looks Abroad For Growth

March 2007 | Company News Alert

With the completion of a state-of-the-art manufacturing plant, Filipino drugmaker United Laboratories (Unilab) believes it is well placed to strengthen its position as the leading domestic pharmaceutical firm and expand its international reach. BMI welcomes the development as it will encourage other local drugmakers to increase their capacity at a time when they are attempting to wrest market share from the multinationals. Approximately 75% of the pharmaceutical market is held by large foreign producers, but we expect this figure to decrease by at least ten percentage points by 2011. BMI currently values the Filipino drug market at PHP94.8bn (US$1.95bn) and

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.